HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GSK Consumer Healthcare Celebrates Pain Release With UK Panadol Campaign

Executive Summary

GSK Consumer Healthcare wants to “bring to life the emotional transformation” that UK pain sufferers experience when released from discomfort by analgesic brands like Panadol. 

You may also be interested in...

EU Business News: Haleon Launch Date Set, BioGaia Pens Korea Deal, Revive Active Gets Investment

Round-up of the latest European consumer health market news: GSK sets launch date for standalone OTC business Haleon; BioGaia pens distribution deal for Korea; and Ireland's Revive Active secures investment.

Survey Shows Europeans Supplement Responsibly, Favor Vitamin D Especially

The majority of European consumers use dietary supplements and do so responsibly, a recent survey by industry association Food Supplements Europe shows. Reflecting a common concern for well-being and immunity, vitamin D is the most popular supplement ingredient, followed by vitamin C and magnesium. 

European Health Crisis Driving Consumers Towards Self-Care – Stada Report

European consumers are increasingly turning towards self-care options, research by Stada Arzneimittel shows. Especially in the areas of stress, sleep and mental health, they are seeking out alternatives to conventional medicine, such as dietary supplements, and support from new health technologies, like digital health apps.


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts